Paul Manning

Paul Manning

Presidente presso CANDEL THERAPEUTICS, INC.

Patrimonio netto: 564 M $ in data 31/05/2026

70 anni
Health Technology
Technology Services
Commercial Services

Profilo

Paul B. Manning was the founder of PBM Products LLC, founded in 1997, where the title held was President & Chief Executive Officer.
Mr. Manning is the founder of PBM Capital Group LLC, founded in 2010, holding the titles of Chairman and CEO.
Mr. Manning is also the founder of Able Laboratories, Inc...
Mr. Manning is President & Chief Executive Officer at PBM Capital Investments LLC.
Mr. Manning is Chairman at Candel Therapeutics, Inc. since 2021.
Mr. Manning is Chairman at Xalud Therapeutics, Inc. Mr. Manning is Chairman at Verrica Pharmaceuticals, Inc. since 2017.
Mr. Manning is Director at PatientsLikeMe LLC since 2022.
Mr. Manning is Director at The Foundation Fighting Blindness, Inc. Mr. Manning is Director at Foundation Fighting Blindness Clinical Research Institute.
Mr. Manning is Director at PBM Pharmaceuticals, Inc. Mr. Manning is Independent Director at ArcherDX LLC since 2015.
Mr. Manning is Director at Tolerion, Inc. Mr. Manning is Director at UVA Health Foundation.
Mr. Manning is Independent Director at Liquidia Corp.
since 2020.
Mr. Manning was Chairman at Dova Pharmaceuticals, Inc. from 2017 to 2019.
Mr. Manning was Director at QIAGEN Beverly LLC.
Mr. Manning was Director at Gen9, Inc. Mr. Manning was Director at Advanz Pharma Corp.
Ltd. from 2014 to 2015.
Mr. Manning was Independent Director at Novartis Gene Therapies, Inc. from 2014 to 2018.
Mr. Manning was Independent Director at Taysha Gene Therapies, Inc. from 2020 to 2023.
Mr. Manning was Director at Liquidia PAH LLC from 2018 to 2020.
Mr. Manning was Executive Vice President & General Manager at Perrigo Co. from 2010 to 2014.
Mr. Manning was Principal at Beta-Pro LLC.
Mr. Manning completed undergraduate education at the University of Massachusetts.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
16/06/2026 5.755.992 ( 6,47% ) 356 M $ 31/05/2026
31/03/2026 22.737.407 ( 8,33% ) 133 M $ 31/05/2026
30/06/2026 5.748.279 ( 7,85% ) 48 M $ 31/05/2026
25/11/2025 4.558.183 ( 26,53% ) 26 M $ 31/05/2026

Posizioni attive di Paul Manning

SocietàPosizioneInizio
VERRICA PHARMACEUTICALS INC. Presidente 01/12/2017
LIQUIDIA CORPORATION Direttore/Membro del Consiglio 18/11/2020
CANDEL THERAPEUTICS, INC. Presidente 15/07/2021
Direttore/Membro del Consiglio 19/01/2022
Presidente -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio 01/01/2015
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -

Precedenti posizioni note di Paul Manning

SocietàPosizioneFine
░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Paul Manning

Formazione di Paul Manning

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

58

Relazioni di 1° grado

25

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private25

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Consumer Services

Consumer Non-Durables

Commercial Services

Finance

Beta-Pro LLC

Finance

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Pbm Capital Investments LLC

Technology Services

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Mercati
  2. Insiders
  3. Paul Manning